Suppr超能文献

一种吸附剂辅助腹膜透析系统的体外疗效和安全性。

In vitro efficacy and safety of a system for sorbent-assisted peritoneal dialysis.

机构信息

Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands.

Division of Nephrology, Surgical, Medical, Dental, Morphology Sciences, Transplant, Oncology and Regenerative Medicine Department, University of Modena and Reggio Emilia, Modena, Italy.

出版信息

Am J Physiol Renal Physiol. 2020 Aug 1;319(2):F162-F170. doi: 10.1152/ajprenal.00079.2020. Epub 2020 Jun 1.

Abstract

A system for sorbent-assisted peritoneal dialysis (SAPD) was designed to continuously recirculate dialysate via a tidal mode using a single lumen peritoneal catheter with regeneration of spent dialysate by means of sorbent technology. We hypothesize that SAPD treatment will maintain a high plasma-to-dialysate concentration gradient and increase the mass transfer area coefficient of solutes. Thereby, the SAPD system may enhance clearance while reducing the number of exchanges. Application is envisaged at night as a bedside device (12 kg, nighttime system). A wearable system (2.0 kg, daytime system) may further enhance clearance during the day. Urea, creatinine, and phosphate removal were studied with the daytime and nighttime system ( = 3 per system) by recirculating 2 liters of spent peritoneal dialysate via a tidal mode (mean flow rate: 50 and 100 mL/min, respectively) for 8 h in vitro. Time-averaged plasma clearance over 24 h was modeled assuming one 2 liter exchange/day, an increase in mass transfer area coefficient, and 0.9 liters ultrafiltration/day. Urea, creatinine, and phosphate removal was 33.2 ± 4.1, 5.3 ± 0.5, and 6.2 ± 1.8 mmol, respectively, with the daytime system and 204 ± 28, 10.3 ± 2.4, and 11.4 ± 2.1 mmol, respectively, with the nighttime system. Time-averaged plasma clearances of urea, creatinine and phosphate were 9.6 ± 1.1, 9.6 ± 1.7, and 7.0 ± 0.9 mL/min, respectively, with the nighttime system and 10.8 ± 1.1, 13.4 ± 1.8, and 9.7 ± 1.6 mL/min, respectively, with the daytime and nighttime system. SAPD treatment may improve removal of uremic toxins compared with conventional peritoneal dialysis, provided that peritoneal mass transport will increase.

摘要

设计了一种基于吸附剂的腹膜透析(SAPD)系统,该系统通过使用带有再生功能的单腔腹膜导管以潮汐模式连续循环透析液,从而再生已使用的透析液。我们假设 SAPD 治疗将维持高的血浆-透析液浓度梯度,并增加溶质的传质面积系数。因此,SAPD 系统可以在减少交换次数的同时提高清除率。该系统预计将在夜间作为床边设备(12 千克,夜间系统)应用。可穿戴系统(2.0 千克,日间系统)可能会在白天进一步提高清除率。通过在体外以潮汐模式(平均流速分别为 50 和 100 mL/min)连续循环 2 升已使用的腹膜透析液 8 小时,研究了日间和夜间系统(每个系统 3 次)对尿素、肌酐和磷酸盐的清除率。假设每天进行一次 2 升交换,传质面积系数增加,每天超滤 0.9 升,建立了 24 小时的平均血浆清除率模型。日间系统的尿素、肌酐和磷酸盐的清除率分别为 33.2±4.1、5.3±0.5 和 6.2±1.8 mmol,夜间系统的清除率分别为 204±28、10.3±2.4 和 11.4±2.1 mmol。夜间系统的尿素、肌酐和磷酸盐的平均血浆清除率分别为 9.6±1.1、9.6±1.7 和 7.0±0.9 mL/min,日间和夜间系统的清除率分别为 10.8±1.1、13.4±1.8 和 9.7±1.6 mL/min。与传统的腹膜透析相比,SAPD 治疗可能会提高尿毒症毒素的清除率,前提是腹膜的传质会增加。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验